UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
DICE holding history
DICE Therapeutics, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DICE overviewAll 13F holders of DICEFull Q2 2026 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −399,284−100.0% | Sold out | Holders |
| Q2 2023 | 399,284 | $18.6M | <0.1% | +383,140+2,373.3% | Added | Holders |
| Q1 2023 | 16,144 | $462.5K | <0.1% | +7,058+77.7% | Added | Holders |
| Q4 2022 | 9,086 | $283.5K | <0.1% | +8,963+7,287.0% | Added | Holders |
| Q3 2022 | 123 | $2.00K | <0.1% | +123 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −2,059−100.0% | Sold out | Holders |
| Q1 2022 | 2,059 | $39.0K | <0.1% | −2,372−53.5% | Reduced | Holders |
| Q4 2021 | 4,431 | $112.0K | <0.1% | +4,431 | New | Holders |